Skip to content

迪斯克医疗

US · IRON #2647 按市值排名 上市于 1970
56.84 +0.19 +0.34%
实时 - 追踪5344个代码 - 心跳于573秒前 · 2026-10-16 20:01

最新新闻

  • 公司公告
    *ST Bayi Steel: Reply to the Inquiry Letter Regarding the Review of the Application Documents for the Issuance of Shares to Specific Investors by Xinjiang Bayi Iron & Steel Co., Ltd.
    SZSI · 2026/10/1
  • 评级变动
    LifeSci Capital Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $100
    \u5e02\u573a\u8d44\u8baf · 2026/9/10
  • 公司公告
    Iron Mountain | 4: Statement of changes in beneficial ownership of securities-Director Samuels Theodore R. II
    SEC · 2026/10/6
  • UBS Initiates CHAMPION IRON LTD(CIAFF.US) With Buy Rating, Announces Target Price $2.89
    \u5e02\u573a\u8d44\u8baf · 2026/9/29
  • 评级变动
    Baoshan Iron & Steel Co., Ltd. (600019): Profitability Remains Leading; High Dividend Yield Expected to Persist
    Cathay Haitong Securities · 2026/9/24
  • Iron Mountain(IRM.US) Officer Sells US$4.25 Million in Common Stock
    \u5e02\u573a\u8d44\u8baf · 2026/10/6
  • Maanshan Iron & Steel Co., Ltd. (600808.SH): Appointed Chen Guorong as Deputy General Manager and Chief Financial Officer
    Gelonghui Finance · 2026/9/29
  • 公司公告
    *ST Bayi Steel: Explanation by Tianjian Certified Public Accountants (Special General Partnership) Regarding Financial Matters in the Inquiry Letter on the Review of Xinjiang Bayi Iron & Steel Co., Ltd.'s Issuance of Shares to Specific Investors
    SZSI · 2026/10/1
  • Maanshan Iron & Steel Company Limited (600808.SH): Jiang Yuxiang Elected as Chairman of the Board
    Gelonghui Finance · 2026/9/29
  • 评级变动
    BMO Capital Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $100
    \u5e02\u573a\u8d44\u8baf · 2026/9/11
  • 评级变动
    Wells Fargo Maintains Disc Medicine(IRON.US) With Buy Rating, Raises Target Price to $86
    \u5e02\u573a\u8d44\u8baf · 2026/9/16
  • 评级变动
    Rothschild & Co Redburn Initiates Iron Mountain(IRM.US) With Buy Rating, Announces Target Price $132
    \u5e02\u573a\u8d44\u8baf · 2026/9/21
  • 评级变动
    H.C. Wainwright Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $120
    \u5e02\u573a\u8d44\u8baf · 2026/9/22
  • 评级变动
    Champion Iron Price Target Cut 29% to A$4.80/Share by Macquarie
    Dow Jones · 2026/10/2
  • 评级变动
    Stifel Maintains Iron Mountain(IRM.US) With Buy Rating, Maintains Target Price $140
    \u5e02\u573a\u8d44\u8baf · 2026/9/18
  • 公司公告
    *ST Bayi Steel: Supplementary Legal Opinion of King & Wood Mallesons Shanghai regarding the 2026 issuance of A‑shares to specific investors by Xinjiang Bayi Iron & Steel Co., Ltd.
    SZSI · 2026/10/1
  • Maanshan Iron & Steel Co., Ltd. (600808.SH): Appoints Fu Ming as General Manager
    Gelonghui Finance · 2026/9/29
  • 评级变动
    Liuzhou Iron & Steel Co., Ltd. (601003): A leading steel producer in the Guangxi region, with equity production capacity poised for further expansion.
    Everbright Securities · 2026/9/30
  • 评级变动
    Truist Financial Maintains Disc Medicine(IRON.US) With Buy Rating
    \u5e02\u573a\u8d44\u8baf · 2026/9/21
  • 公司公告
    Shandong Iron & Steel: Announcement on the Progress of Share Purchases by Senior Management of Shandong Iron & Steel Co., Ltd.
    SZSI · 2026/10/1

新闻标题为自动聚合内容,未经我们团队独立核实或编辑。

报价时间 2026-10-16 20:01:07 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

迪斯克医疗 讨论区 0 条评论

发表评论